Clinical Trial Update: PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant therapy with a PD-1 inhibitor plus gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PD-1 inhibitor

Snippet

Sponsor: Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING